• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死性筋膜炎和肌炎的预后因素:瑞士一家机构连续16例病例分析

Prognostic factors in necrotizing fasciitis and myositis: analysis of 16 consecutive cases at a single institution in Switzerland.

作者信息

Rieger Ulrich M, Gugger Christine Y, Farhadi Jian, Heider Ilonka, Andresen Reimer, Pierer Gerhard, Scheufler Oliver

机构信息

Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospital of Basel, Basel, Switzerland.

出版信息

Ann Plast Surg. 2007 May;58(5):523-30. doi: 10.1097/01.sap.0000244978.27053.08.

DOI:10.1097/01.sap.0000244978.27053.08
PMID:17452837
Abstract

Necrotizing fasciitis and myositis are life-threatening infections involving the superficial fascia and musculature, respectively. Outcome depends on early diagnosis and aggressive treatment. Here, we aimed to determine prognostic factors for necrotizing soft tissue infections.The medical records of 16 consecutive patients diagnosed with necrotizing fasciitis (n = 13) and necrotizing myositis (n = 3) from 1999 to 2004 were retrospectively reviewed. Overall survival was 81.3% for necrotizing soft tissue infections, 84.6% for necrotizing fasciitis, and 66.7% for necrotizing myositis. Injection drug use was the most common cause of infection (31.3%). Frequent comorbidities were diabetes mellitus and hepatitis B and C (25.0%). As infectious agents, group A streptococci (GAS) were identified in 10 patients and multiple pathogens in 6 patients. Lethal outcome was always associated with GAS infection and streptococcal toxic shock syndrome (STSS). In our patients, myonecrosis, GAS infection, and STSS appeared to be negative prognostic factors for survival in necrotizing soft tissue infections.

摘要

坏死性筋膜炎和坏死性肌炎分别是累及浅筋膜和肌肉组织的危及生命的感染。预后取决于早期诊断和积极治疗。在此,我们旨在确定坏死性软组织感染的预后因素。回顾性分析了1999年至2004年连续诊断为坏死性筋膜炎(n = 13)和坏死性肌炎(n = 3)的16例患者的病历。坏死性软组织感染的总体生存率为81.3%,坏死性筋膜炎为84.6%,坏死性肌炎为66.7%。注射吸毒是最常见的感染原因(31.3%)。常见的合并症为糖尿病以及乙型和丙型肝炎(25.0%)。作为感染病原体,10例患者中鉴定出A组链球菌(GAS),6例患者中鉴定出多种病原体。致命结局总是与GAS感染和链球菌中毒性休克综合征(STSS)相关。在我们的患者中,肌坏死、GAS感染和STSS似乎是坏死性软组织感染生存的负面预后因素。

相似文献

1
Prognostic factors in necrotizing fasciitis and myositis: analysis of 16 consecutive cases at a single institution in Switzerland.坏死性筋膜炎和肌炎的预后因素:瑞士一家机构连续16例病例分析
Ann Plast Surg. 2007 May;58(5):523-30. doi: 10.1097/01.sap.0000244978.27053.08.
2
Necrotizing fasciitis and myositis caused by streptococcal flesh-eating bacteria.由链球菌引起的坏死性筋膜炎和肌炎。
J Clin Rheumatol. 2010 Dec;16(8):382-4. doi: 10.1097/RHU.0b013e3181fe8ba3.
3
Microbiology and factors affecting mortality in necrotizing fasciitis.坏死性筋膜炎的微生物学及影响死亡率的因素
J Microbiol Immunol Infect. 2005 Dec;38(6):430-5.
4
Necrotizing fasciitis in children: diagnostic and therapeutic aspects.儿童坏死性筋膜炎:诊断与治疗方面
J Pediatr Surg. 2007 Nov;42(11):1892-7. doi: 10.1016/j.jpedsurg.2007.07.018.
5
[Streptococcus group A infections of skin, soft tissue and blood].[甲型链球菌引起的皮肤、软组织及血液感染]
Tidsskr Nor Laegeforen. 2001 Nov 20;121(28):3310-4.
6
A case series describing 118 patients with lower limb necrotizing fasciitis.一项描述118例下肢坏死性筋膜炎患者的病例系列研究。
Int J Low Extrem Wounds. 2009 Jun;8(2):112-6. doi: 10.1177/1534734609334809.
7
Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus.评估非甾体抗炎药的使用与A组链球菌引起的坏死性筋膜炎之间的关系。
Medicine (Baltimore). 2003 Jul;82(4):225-35. doi: 10.1097/01.md.0000085060.63483.bb.
8
Necrotizing fasciitis with no mortality or limb loss.无死亡或肢体缺失的坏死性筋膜炎。
Am Surg. 2008 Sep;74(9):809-12.
9
[Necrotising fasciitis caused by streptococcal toxic shock syndrome].[链球菌中毒性休克综合征所致坏死性筋膜炎]
Handchir Mikrochir Plast Chir. 2002 Mar;34(2):108-14. doi: 10.1055/s-2002-32302.
10
Marine bacteria as a leading cause of necrotizing fasciitis in coastal areas of South Korea.海洋细菌是韩国沿海地区坏死性筋膜炎的主要病因。
Am J Trop Med Hyg. 2009 Apr;80(4):646-50.

引用本文的文献

1
Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands-A Case Series from a Tertiary Referral Center.下肢坏死性软组织感染的管理:显微外科重建与医院资源需求——来自三级转诊中心的病例系列
J Clin Med. 2025 Apr 26;14(9):2997. doi: 10.3390/jcm14092997.
2
Group A Streptococcus necrotising myositis of the limbs secondary to cavitating pneumonia.A 组链球菌所致四肢坏疽性肌炎继发于有空腔的肺炎。
BMJ Case Rep. 2021 Apr 7;14(4):e239929. doi: 10.1136/bcr-2020-239929.
3
Predicting Morbidity and Mortality in Patients with Lower Extremity Necrotizing Fasciitis.
预测下肢坏死性筋膜炎患者的发病率和死亡率。
Sisli Etfal Hastan Tip Bul. 2019 Feb 4;53(1):27-32. doi: 10.14744/SEMB.2019.57778. eCollection 2019.
4
Necrotizing streptococcal myositis of the upper extremity: a case report.上肢坏死性链球菌性肌炎:一例报告
BMC Res Notes. 2017 Aug 15;10(1):407. doi: 10.1186/s13104-017-2743-1.
5
Necrotizing fasciitis: epidemiology and clinical predictors for amputation.坏死性筋膜炎:截肢的流行病学及临床预测因素
Int J Gen Med. 2015 May 14;8:195-202. doi: 10.2147/IJGM.S82999. eCollection 2015.
6
Contemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort study.德克萨斯州坏死性筋膜炎的流行病学、临床特征及资源利用的当代趋势:一项基于人群的队列研究
Crit Care Res Pract. 2015;2015:618067. doi: 10.1155/2015/618067. Epub 2015 Mar 29.
7
Necrotising myositis, the deadly impersonator.坏死性肌炎,致命的伪装者。
Case Rep Surg. 2014;2014:485651. doi: 10.1155/2014/485651. Epub 2014 Nov 19.
8
Fatal necrotising fasciitis after spinal anaesthesia.脊髓麻醉后发生致命性坏死性筋膜炎。
J Cutan Aesthet Surg. 2013 Jul;6(3):165-6. doi: 10.4103/0974-2077.118429.
9
A rare case of necrotising fasciitis after spinal anaesthesia.一例罕见的脊髓麻醉后坏死性筋膜炎病例。
Indian J Anaesth. 2013 May;57(3):316-8. doi: 10.4103/0019-5049.115594.
10
Fulminant necrotizing fasciitis following the use of herbal concoction: a case report.使用草药汤剂后发生暴发性坏死性筋膜炎:一例报告
J Med Case Rep. 2010 Oct 19;4:326. doi: 10.1186/1752-1947-4-326.